0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Prescribing Behavior
 41-60 of 136 Articles
Invited Commentary | 
Jeffrey A. Linder, MD, MPH
JAMA Intern Med. 2013;173(4):273-275. doi:10.1001/jamainternmed.2013.1984.

Original Investigation |  FREE
Ralph Gonzales, MD, MSPH; Tammy Anderer, PhD, CRNP; Charles E. McCulloch, PhD; et al.
JAMA Intern Med. 2013;173(4):267-273. doi:10.1001/jamainternmed.2013.1589.

Editorial | 
Mitchell H. Katz, MD
JAMA Intern Med. 2013;173(3):178. doi:10.1001/jamainternmed.2013.1838.

Research Letters |  FREE
Maya Vijayaraghavan, MD, MAS; Joanne Penko, MS, MPH; David R. Bangsberg, MD, MPH; et al.
JAMA Intern Med. 2013;173(3):235-237. doi:10.1001/jamainternmed.2013.1576.
Includes: Supplemental Content

Perspectives |  FREE
Rita F. Redberg, MD, MSc
JAMA Intern Med. 2013;173(3):179. doi:10.1001/jamainternmed.2013.3378.

Invited Commentary | 
Brian K. Alldredge, PharmD; Steven R. Kayser, PharmD
JAMA Intern Med. 2013;173(3):233-234. doi:10.1001/jamainternmed.2013.1777.

Research Letters |  FREE
Eric G. Campbell, PhD; Genevieve Pham-Kanter, PhD; Christine Vogeli, PhD; et al.
JAMA Intern Med. 2013;173(3):237-239. doi:10.1001/jamainternmed.2013.1539.

Invited Commentary | 
Lawrence X. Yu, PhD; Gregory P. Geba, MD, MPH
JAMA Intern Med. 2013;173(3):208-209. doi:10.1001/jamainternmed.2013.2283.

Research Letters |  FREE
Tarayn Fairlie, MD, MPH; Daniel J. Shapiro, BA; Adam L. Hersh, MD, PhD; et al.
Arch Intern Med. 2012;172(19):1513-1514. doi:10.1001/archinternmed.2012.4089.

Original Investigation |  FREE
Yuting Zhang, PhD; Michael A. Steinman, MD; Cameron M. Kaplan, PhD
Arch Intern Med. 2012;172(19):1465-1471. doi:10.1001/archinternmed.2012.3717.
Includes: Supplemental Content

Invited Commentary | 
Ralph Gonzales, MD, MSPH; Sara Ackerman, PhD, MPH; Margaret Handley, PhD, MPH
Arch Intern Med. 2012;172(19):1471-1473. doi:10.1001/2013.jamainternmed.532.

Invited Commentary | 
Paula A. Rochon, MD, MPH; Jerry H. Gurwitz, MD
Arch Intern Med. 2012;172(19):1499-1500. doi:10.1001/2013.jamainternmed.332.

Invited Commentary | 
Daniel J. Brotman, MD; Amir K. Jaffer, MD
Arch Intern Med. 2012;172(19):1492-1493. doi:10.1001/archinternmed.2012.4309.

Invited Commentary | 
Daniel R. Kuritzkes, MD
Arch Intern Med. 2012;172(17):1321-1323. doi:10.1001/archinternmed.2012.3644.

Original Investigation |  FREE
Luigia Elzi, MD, MSc; Stefan Erb, MD; Hansjakob Furrer, MD; et al.
Arch Intern Med. 2012;172(17):1313-1321. doi:10.1001/archinternmed.2012.3216.

Commentary | 
Jane C. Ballantyne, MD, FRCA; Mark D. Sullivan, MD, PhD; Andrew Kolodny, MD
Arch Intern Med. 2012;172(17):1342-1343. doi:10.1001/archinternmed.2012.3212.

Research Letters |  FREE
Raman Ravi Khanna, MD, MAS; Ronald G. Victor, MD; Kirsten Bibbins-Domingo, PhD, MD; et al.
Arch Intern Med. 2012;172(17):1344-1345. doi:10.1001/archinternmed.2012.2749.
Includes: Supplemental Content

Invited Commentary | 
Peter W. Groeneveld, MD, MS
Arch Intern Med. 2012;172(15):1152-1153. doi:10.1001/archinternmed.2012.2724.

Perspectives |  FREE
Irene M. Wielawski
Arch Intern Med. 2012;172(15):1131. doi:10.1001/archinternmed.2012.2378.

Research Letters |  FREE
Genevieve Pham-Kanter, PhD; G. Caleb Alexander, MD, MS; Kavita Nair, PhD
Arch Intern Med. 2012;172(10):819-821. doi:10.1001/archinternmed.2012.1210.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA
From the JAMA Network  | 
Treating Prescription Opioid Dependence
Charles Ruetsch, PhD
JAMA
Medical News & Perspectives  | 
Reports: HIV Drugs Targeted for Black Market
Bridget M. Kuehn, MSJ
JAMA
Medical News & Perspectives  | 
CDC: Major Disparities in Opioid Prescribing Among States:  Some States Crack Down on Excess Prescribing
Bridget M. Kuehn, MSJ
JAMA Neurology
Editorial  | 
Does Natalizumab Therapy Benefit Patients With Multiple Sclerosis?
Olaf Stüve, MD, PhD; Gary R. Cutter, PhD